Roberts Glore & Co. Inc. IL Acquires New Stake in CME Group Inc. $CME

Key Points

• Roberts Glore & Co. acquired 7,024 CME Group shares during the second quarter, valued at approximately $1.55 million. Institutional investors collectively own 87.75% of the company.
• CME Group reported quarterly EPS of $2.99, beating estimates of $2.91, while revenue reached $1.71 billion and rose 0.8% year over year.
• The company declared a quarterly dividend of $1.30 per share, or $5.20 annualized, representing a 1.9% yield. Analysts’ average rating is “Hold,” with a consensus price target of $288.56.

Roberts Glore & Co. Inc. IL acquired a new stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 7,024 shares of the financial services provider's stock, valued at approximately $1,551,000.

A number of other institutional investors and hedge funds have also bought and sold shares of CME. Northwestern Mutual Investment Management Company LLC grew its stake in shares of CME Group by 0.3% in the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider's stock worth $3,147,000 after acquiring an additional 37 shares during the period. Rehmann Capital Advisory Group increased its stake in shares of CME Group by 4.3% in the 3rd quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider's stock worth $243,000 after purchasing an additional 37 shares in the last quarter. Endowment Wealth Management Inc. increased its position in CME Group by 4.4% in the fourth quarter. Endowment Wealth Management Inc. now owns 895 shares of the financial services provider's stock worth $244,000 after buying an additional 38 shares in the last quarter. NBT Bank N A NY increased its holdings in CME Group by 2.3% in the 1st quarter. NBT Bank N A NY now owns 1,666 shares of the financial services provider's stock worth $492,000 after acquiring an additional 38 shares in the last quarter. Finally, Resonant Capital Advisors LLC raised its position in shares of CME Group by 3.8% during the 1st quarter. Resonant Capital Advisors LLC now owns 1,073 shares of the financial services provider's stock valued at $317,000 after purchasing an additional 39 shares during the period. 87.75% of the stock is currently owned by institutional investors.

CME Group Trading Down 0.7%

Shares of CME opened at $277.32 on Wednesday. CME Group Inc. has a 52-week low of $218.31 and a 52-week high of $329.16. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The stock has a market cap of $99.72 billion, a PE ratio of 23.52, a price-to-earnings-growth ratio of 3.32 and a beta of 0.23. The firm's fifty day moving average is $251.75 and its two-hundred day moving average is $279.35.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The firm had revenue of $1.71 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same period last year, the company earned $2.96 EPS. The company's quarterly revenue was up .8% on a year-over-year basis. Research analysts forecast that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be paid a $1.30 dividend. The ex-dividend date is Wednesday, September 9th. This represents a $5.20 dividend on an annualized basis and a yield of 1.9%. CME Group's payout ratio is currently 44.11%.

Wall Street Analyst Weigh In

Several research firms have recently commented on CME. Barclays lowered their target price on shares of CME Group from $316.00 to $270.00 and set an "equal weight" rating on the stock in a report on Thursday, July 9th. Bank of America upped their target price on shares of CME Group from $226.00 to $230.00 and gave the company an "underperform" rating in a research report on Thursday, July 23rd. Keefe, Bruyette & Woods upgraded CME Group from a "market perform" rating to an "outperform" rating and set a $305.00 price target for the company in a research report on Thursday, June 18th. Erste Group Bank lowered shares of CME Group from a "buy" rating to a "hold" rating in a research note on Friday, June 5th. Finally, Weiss Ratings downgraded CME Group from a "buy (b-)" rating to a "hold (c+)" rating in a report on Tuesday, August 11th. Nine investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company. According to MarketBeat, CME Group presently has an average rating of "Hold" and a consensus price target of $288.56.

Insider Buying and Selling

In other CME Group news, Director William R. Shepard purchased 325 shares of the firm's stock in a transaction on Thursday, June 25th. The stock was bought at an average cost of $230.57 per share, with a total value of $74,935.25. Following the acquisition, the director directly owned 260,442 shares of the company's stock, valued at approximately $60,050,111.94. This represents a 0.12% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.30% of the stock is owned by company insiders.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source